Search
Search
Close this search box.

A look at percentage of legal versus illicit cannabis sales

The Canada Cannabis Spot Index was assessed at C$5.17 per gram this week, down 0.2% from last week’s C$5.18 per gram. This week’s price equates to US$1,860 per pound at the current exchange rate.

Each week, Business of Cannabis delivers a series of insights from our partners at Cannabis Benchmarks®.

This week, Cannabis Benchmarks look into the latest household expenditure data from Statistics Canada, issued quarterly.

The first thing to note from the data is that the total dollars spent on cannabis has been on a steady rise since legalization. Statistics Canada estimates a total of C$1.91B was spent on cannabis in Q2 2021 in both the legal medical and recreational markets, as well as the illicit market. This figure is 36% higher than the amount spent in the same quarter in 2018, which shows the increase in mainstream adoption of cannabis use since the onset of legalization.

In the chart above, Cannabis Benchmarks took the same dataset and split out the source and use of the cannabis sale. The chart shows that the legal recreational cannabis sector has been growing substantially over the past few years. The legal recreational market is not only taking market share from the illicit market but also growing overall cannabis expenditures. Statistics Canada estimates illicit recreational sales have fallen 9.7% to C$0.74B from Q2 2020 to Q2 2021. As legal recreational sales have grown to 55% of total cannabis purchases, legal medical sales and the number of medical clients actively registered with licensed producers have also declined.

Source: Canada Cannabis Spot IndexCannabis Benchmarks

See previous weekly updates from Cannabis Benchmarks:



⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?